JP Stock MarketDetailed Quotes

4554 Fuji Pharma

Watchlist
  • 1305
  • +12+0.93%
20min DelayNot Open Nov 7 15:30 JST
32.30BMarket Cap9.23P/E (Static)

Fuji Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Fuji Pharma FY2024 Estimates Date

Currency：JPYNov 12, 2024

Estimate YoY
Revenue
45.98B
+12.46%
EPS
236.30
+67.15%
Analyst Rating
Strong Buy

Aug 9, 2024

Fuji Pharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Aug 8, 20242024/Q311.767B / 12.300B--
May 9, 20242024/Q210.642B / 11.254B--
Feb 8, 20242024/Q110.746B / 11.700B--
Nov 9, 20232023/Q411.407B / 11.018B--
Aug 8, 20232023/Q310.257B / 11.475B--
DatePeriodRevenue/EstimateEarnings Call
Aug 8, 20242024/Q311.767B / 12.300B--
May 9, 20242024/Q210.642B / 11.254B--
Feb 8, 20242024/Q110.746B / 11.700B--
Nov 9, 20232023/Q411.407B / 11.018B--
Aug 8, 20232023/Q310.257B / 11.475B--

Unlock Free Earnings Estimates

Fuji Pharma Earnings Reports

  • Fuji Pharma: Short message for the third quarter financial results (consolidated) for the period of September 2024 [Japanese standard]

    Aug 8 03:30 ET

  • Fuji Pharma: Confirmation letter

    May 10 01:27 ET

  • Fuji Pharma: Quarterly Report - 60th Quarter 2 (2024/01/01 to 2024/03/31)

    May 10 01:27 ET

  • Fuji Pharma: Notice regarding differences between second-quarter earnings forecasts and actual results and partial revisions to full-year earnings forecasts

    May 9 04:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Aug 9, 2024

    Strong Buy

    • Strong Buy

      100.00%

    • Buy

      0.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    JP
    Overall
    Symbol
    Latest Price
    % Chg

    No Data